- Home
- STWD vs PCVX Comparison
STWD vs PCVX Comparison
Compare STWD & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | STWD | PCVX |
|---|---|---|
| Founded | 2009 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.4B | 6.1B |
| IPO Year | 2009 | 2020 |
Fundamental Metrics
Financial Performance| Metric | STWD | PCVX |
|---|---|---|
| Price | $18.20 | $55.19 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 7 |
| Target Price | $20.63 | ★ $97.67 |
| AVG Volume (30 Days) | ★ 3.6M | 1.6M |
| Earning Date | 02-25-2026 | 02-25-2026 |
| Dividend Yield | ★ 10.68% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.04 | N/A |
| Revenue | ★ $490,651,000.00 | N/A |
| Revenue This Year | $366.38 | N/A |
| Revenue Next Year | $12.15 | N/A |
| P/E Ratio | $17.27 | ★ N/A |
| Revenue Growth | ★ 12.42 | N/A |
| 52 Week Low | $16.59 | $27.66 |
| 52 Week High | $21.05 | $87.42 |
Technical Indicators
Market Signals| Indicator | STWD | PCVX |
|---|---|---|
| Relative Strength Index (RSI) | 49.25 | 60.54 |
| Support Level | $17.88 | $53.12 |
| Resistance Level | $18.49 | $58.00 |
| Average True Range (ATR) | 0.29 | 3.29 |
| MACD | -0.00 | 0.10 |
| Stochastic Oscillator | 60.11 | 60.98 |
Price Performance
Historical ComparisonAbout STWD STARWOOD PROPERTY TRUST INC. Starwood Property Trust Inc.
Starwood Property Trust Inc is an American real estate investment trust principally engaged in originating, acquiring, and managing commercial mortgage loans and commercial mortgage-backed securities in the U.S. and Europe. The company organizes its activities into Commercial and Residential Lending Segment, Infrastructure Lending Segment, Property Segment, and Investing & Servicing Segment. The company generates the majority of its revenue from the Commercial and Residential Lending Segment, which is engaged in originating, acquiring, financing, and managing commercial first mortgages, and non-agency residential mortgages.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.